#GivingTuesday Matching Gift Challenge

#GivingTuesday is a global day of giving fueled by the power of social media and collaboration.  This year your donation can go even further with our generous matching gift challenge! For every dollar donated this year, a special donor will match up to $10,000!  Dollar for dollar!

We want to fund more research, increase our engagement with industry, offer a broader range of professional development opportunities, and continue to develop life-changing initiatives for individuals like you.

Today, we are asking you to invest with us, so that together, we can take another giant step closer to achieving our dreams.

Please know that every contribution, large and small, will make a difference. By working together, we can assure that people with vasculitis get diagnosed sooner, gain the support they need to best manage their disease, and, live longer, healthier lives.


Thank you for your support! 

Vasculitis Foundation

The Vasculitis Foundation is the international organization for patients with vasculitis, their families, friends and the health care professionals who care for them.


VF Announces 2018 V-RED Awardees

The Vasculitis Foundation is pleased to announce Dr. Linda Brady, a pediatrician with Vanderbilt, is the winner of its 2018 Recognizing Excellence in Diagnostics (V-RED) Award.  The award is presented annually to more »

VF Celebrates Vasculitis Awareness Month 2018

The Vasculitis Foundation, the world’s largest organization dedicated to providing advocacy, education and support for people with vasculitis, announces the launch of Vasculitis Awareness Month (May 2018), an annual effort more »


Introducing our 2017-2018 VCRC-VF Fellow

Kaitlin Quinn, MD, is the recipient of the 2017 VCRC-VF Fellowship.  She received her medical degree from New York Medical College in Valhalla, New York.   She completed her Internal Medicine more »

FDA Approves Genentech’s Actemra® for Giant Cell Arteritis

Genentech, a member of the Roche Group, announced today (May 22, 2017) that the U.S. Food and Drug Administration (FDA) has approved Actemra® (tocilizumab) subcutaneous injection for the treatment of more »